ArticleScientific reports2025
A modular and adaptable approach for automated morphological feature extraction in meibography images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Fiducial-Marker-Based Localization Method for Automotive Chassis Bolt Assembly.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a modular and adaptable approach for the automated extraction of morphological features from meibography images, focusing on Meibomian gland (MG) analysis. The proposed method leverages piecewise linear modeling to derive clinically interpretable metrics that capture key structural characteristics of MGs. The workflow consists of three main stages: (1) semi-automated region of interest (ROI) selection, (2) MG identification and segmentation, and (3) extraction of gland- and image-level metrics. The approach was validated using 616 meibography images from two different imaging systems, demonstrating robustness, adaptability, and high classification accuracy for Meiboscale grading. Key metrics such as the shortening ratio and dropout area proved effective in distinguishing different stages of Meibomian gland dysfunction (MGD). By balancing automation, interpretability, and computational efficiency, this method provides a practical and scalable tool for the objective assessment of MG morphology, with potential applications in clinical practice and large-scale ophthalmic research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.